---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-027465"
form_type: "8-K"
ticker: "STXS"
cik: "0001289340"
company_name: "Stereotaxis, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T16:42:23.104830+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Stereotaxis Q2 revenue $7.9M (+28% YoY), net loss $5.0M, cash $23.9M

## Summary
- Revenue $7.9M, up 28% YoY; system revenue $3.3M (two Genesis systems), recurring revenue $4.6M.
- Gross margin 53%; operating loss ($5.3M), net loss ($5.0M); adjusted net loss ($2.4M).
- Cash $23.9M, no debt; expects year-end cash $22-24M; no additional financing needed.
- Orders for two Genesis systems in Q2; system backlog $16M; guidance of double-digit revenue growth in 2023.
- Announced strategic Abbott collaboration for EnSite X integration; MAGiC catheter study submitted.

## SEC filing metadata
- accession: 0001493152-23-027465
- form_type: 8-K
- ticker: STXS
- cik: 0001289340
- company_name: Stereotaxis, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289340/000149315223027465/0001493152-23-027465-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289340/000149315223027465/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-027465
- JSON: https://secwatch.observer/filing/0001493152-23-027465.json
- Plain text: https://secwatch.observer/filing/0001493152-23-027465.txt

## Key facts
- Earnings Releases
  Stereotaxis, Inc. reported second quarter ended June 30, 2023 results: revenue $7.9 million, net income ($5.0) million.
  - Period: second quarter ended June 30, 2023
  - Revenue: $7.9 million
  - Net income: ($5.0) million
  - Result: reported results
  source text: its commercialization, and reach profitability without the need for additional financing.” 2023 Second Quarter Financial Results Revenue for the second quarter of 2023 totaled $7.9 million, a 28% year-over-year increase compared to $6.2 million in the prior year second quarter. System revenue for the quarter was $3.3 million and recurring revenue was $4.6 million,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1289340/000149315223027465/0001493152-23-027465-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.